Clinicopathological effects of body composition measurements for patients with endometrial cancer
Minerva Ginecol
.
2020 Dec;72(6):430-435.
doi: 10.23736/S0026-4784.20.04629-8.
Epub 2020 Jul 28.
Authors
Christopher G Smith
1
,
Deepti Sharma
2
,
Hagen Smith
3
,
Shelley Zippay
4
,
Liza Bastin
5
,
Luis Acosta-Briceno
6
,
James Lee
7
,
Brent Shelton
8
,
Justin Gorski
2
9
,
Anthony Mcdowell
2
9
,
Brian Burgess
2
9
,
Tricia Fredericks
10
,
Rachel Miller
2
9
,
Christopher Desimone
2
9
,
Charles Dietrich
2
9
,
Holly Gallion
2
9
,
Frederick Ueland
2
9
,
Edward Pavlik
2
9
,
John Vannagell
2
9
,
Lauren Baldwin
2
9
Affiliations
1
Division of Gynecologic Oncology, Department of Gynecology and Obstetrics, Emory University, Atlanta, GA, USA - christopher.smith2@emory.edu.
2
Department of Obstetrics and Gynecology, University of Kentucky, Lexington, KY, USA.
3
Department of Obstetrics and Gynecology, TriHealth Good Samaritan Hospital, Cincinnati, OH, USA.
4
Department of Obstetrics and Gynecology, New Hanover Regional Medical Center, Wilmington, NC, USA.
5
Department of Internal Medicine, University of Kentucky, Lexington, KY, USA.
6
Department of Radiology, University of Kentucky, Lexington, KY, USA.
7
Emergency Radiology and Abdominal Radiology, University of Kentucky, Lexington, KY, USA.
8
Department of Biostatistics, Markey Cancer Center, University of Kentucky, Lexington, KY, USA.
9
Division of Gynecologic Oncology, Markey Cancer Center, Lexington, KY, USA.
10
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Nebraska Medical Center, Omaha, NE, USA.
PMID:
32720803
DOI:
10.23736/S0026-4784.20.04629-8
No abstract available
MeSH terms
Body Composition
Endometrial Neoplasms*
Female
Humans